Selected research
Industry Growth & Trends
Global Epilepsy Devices Industry Growth and Trends Forecast to 2032
Market perspective
The global Epilepsy Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Epilepsy Devices include Medtronic, Nihon Kohden Corporation, Neuropace, Natus Medical Incorporated, Medpage, MC10, Liva Nova, Koninklijke Philips and Jude Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Epilepsy Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Epilepsy Devices market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epilepsy Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epilepsy Devices.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Epilepsy Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Epilepsy Devices Market by Company
Medtronic
Nihon Kohden Corporation
Neuropace
Natus Medical Incorporated
Medpage
MC10
Liva Nova
Koninklijke Philips
Jude Medical
Empatica
Compumedics
Cerbomed
Boston Scientific Corporation
Epilepsy Devices Segment by Type
Conventional Devices
Wearable Devices
Implantable Devices
Epilepsy Devices Segment by Application
Hospitals
Neurology Centers
Others
Epilepsy Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epilepsy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epilepsy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epilepsy Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epilepsy Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Epilepsy Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional Devices
- Wearable Devices
- Implantable Devices
Applications
- Hospitals
- Neurology Centers
- Others
Companies covered
- Medtronic
- Nihon Kohden Corporation
- Neuropace
- Natus Medical Incorporated
- Medpage
- MC10
- Liva Nova
- Koninklijke Philips
- Jude Medical
- Empatica
- Compumedics
- Cerbomed
- Boston Scientific Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Epilepsy Devices Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Epilepsy Devices Sales Estimates and Forecasts (2021-2032)
- 1.3 Epilepsy Devices Market by Type
- 1.3.1 Conventional Devices
- 1.3.2 Wearable Devices
- 1.3.3 Implantable Devices
- 1.4 Global Epilepsy Devices Market Size by Type
- 1.4.1 Global Epilepsy Devices Market Size Overview by Type (2021-2032)
- 1.4.2 Global Epilepsy Devices Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Epilepsy Devices Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Epilepsy Devices Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Epilepsy Devices Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Epilepsy Devices Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Epilepsy Devices Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Epilepsy Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Epilepsy Devices Industry Trends
- 2.2 Epilepsy Devices Industry Drivers
- 2.3 Epilepsy Devices Industry Opportunities and Challenges
- 2.4 Epilepsy Devices Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Epilepsy Devices Revenue (2021-2026)
- 3.2 Global Top Players by Epilepsy Devices Sales (2021-2026)
- 3.3 Global Top Players by Epilepsy Devices Price (2021-2026)
- 3.4 Global Epilepsy Devices Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Epilepsy Devices Major Company Production Sites & Headquarters
- 3.6 Global Epilepsy Devices Company, Product Type & Application
- 3.7 Global Epilepsy Devices Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Epilepsy Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Epilepsy Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Epilepsy Devices Tier 1, Tier 2, and Tier 3
4 Epilepsy Devices Regional Status and Outlook
- 4.1 Global Epilepsy Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Epilepsy Devices Historic Market Size by Region
- 4.2.1 Global Epilepsy Devices Sales in Volume by Region (2021-2026)
- 4.2.2 Global Epilepsy Devices Sales in Value by Region (2021-2026)
- 4.2.3 Global Epilepsy Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Epilepsy Devices Forecasted Market Size by Region
- 4.3.1 Global Epilepsy Devices Sales in Volume by Region (2027-2032)
- 4.3.2 Global Epilepsy Devices Sales in Value by Region (2027-2032)
- 4.3.3 Global Epilepsy Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Epilepsy Devices by Application
- 5.1 Epilepsy Devices Market by Application
- 5.1.1 Hospitals
- 5.1.2 Neurology Centers
- 5.1.3 Others
- 5.2 Global Epilepsy Devices Market Size by Application
- 5.2.1 Global Epilepsy Devices Market Size Overview by Application (2021-2032)
- 5.2.2 Global Epilepsy Devices Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Epilepsy Devices Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Epilepsy Devices Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Epilepsy Devices Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Epilepsy Devices Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Epilepsy Devices Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Epilepsy Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Medtronic Epilepsy Devices Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Nihon Kohden Corporation
- 6.2.1 Nihon Kohden Corporation Company Information
- 6.2.2 Nihon Kohden Corporation Business Overview
- 6.2.3 Nihon Kohden Corporation Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Nihon Kohden Corporation Epilepsy Devices Product Portfolio
- 6.2.5 Nihon Kohden Corporation Recent Developments
- 6.3 Neuropace
- 6.3.1 Neuropace Company Information
- 6.3.2 Neuropace Business Overview
- 6.3.3 Neuropace Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Neuropace Epilepsy Devices Product Portfolio
- 6.3.5 Neuropace Recent Developments
- 6.4 Natus Medical Incorporated
- 6.4.1 Natus Medical Incorporated Company Information
- 6.4.2 Natus Medical Incorporated Business Overview
- 6.4.3 Natus Medical Incorporated Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Natus Medical Incorporated Epilepsy Devices Product Portfolio
- 6.4.5 Natus Medical Incorporated Recent Developments
- 6.5 Medpage
- 6.5.1 Medpage Company Information
- 6.5.2 Medpage Business Overview
- 6.5.3 Medpage Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Medpage Epilepsy Devices Product Portfolio
- 6.5.5 Medpage Recent Developments
- 6.6 MC10
- 6.6.1 MC10 Company Information
- 6.6.2 MC10 Business Overview
- 6.6.3 MC10 Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 MC10 Epilepsy Devices Product Portfolio
- 6.6.5 MC10 Recent Developments
- 6.7 Liva Nova
- 6.7.1 Liva Nova Company Information
- 6.7.2 Liva Nova Business Overview
- 6.7.3 Liva Nova Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Liva Nova Epilepsy Devices Product Portfolio
- 6.7.5 Liva Nova Recent Developments
- 6.8 Koninklijke Philips
- 6.8.1 Koninklijke Philips Company Information
- 6.8.2 Koninklijke Philips Business Overview
- 6.8.3 Koninklijke Philips Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Koninklijke Philips Epilepsy Devices Product Portfolio
- 6.8.5 Koninklijke Philips Recent Developments
- 6.9 Jude Medical
- 6.9.1 Jude Medical Company Information
- 6.9.2 Jude Medical Business Overview
- 6.9.3 Jude Medical Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jude Medical Epilepsy Devices Product Portfolio
- 6.9.5 Jude Medical Recent Developments
- 6.10 Empatica
- 6.10.1 Empatica Company Information
- 6.10.2 Empatica Business Overview
- 6.10.3 Empatica Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Empatica Epilepsy Devices Product Portfolio
- 6.10.5 Empatica Recent Developments
- 6.11 Compumedics
- 6.11.1 Compumedics Company Information
- 6.11.2 Compumedics Business Overview
- 6.11.3 Compumedics Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Compumedics Epilepsy Devices Product Portfolio
- 6.11.5 Compumedics Recent Developments
- 6.12 Cerbomed
- 6.12.1 Cerbomed Company Information
- 6.12.2 Cerbomed Business Overview
- 6.12.3 Cerbomed Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Cerbomed Epilepsy Devices Product Portfolio
- 6.12.5 Cerbomed Recent Developments
- 6.13 Boston Scientific Corporation
- 6.13.1 Boston Scientific Corporation Company Information
- 6.13.2 Boston Scientific Corporation Business Overview
- 6.13.3 Boston Scientific Corporation Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Boston Scientific Corporation Epilepsy Devices Product Portfolio
- 6.13.5 Boston Scientific Corporation Recent Developments
7 North America by Country
- 7.1 North America Epilepsy Devices Sales by Country
- 7.1.1 North America Epilepsy Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Epilepsy Devices Sales by Country (2021-2026)
- 7.1.3 North America Epilepsy Devices Sales Forecast by Country (2027-2032)
- 7.2 North America Epilepsy Devices Market Size by Country
- 7.2.1 North America Epilepsy Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Epilepsy Devices Market Size by Country (2021-2026)
- 7.2.3 North America Epilepsy Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Epilepsy Devices Sales by Country
- 8.1.1 Europe Epilepsy Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Epilepsy Devices Sales by Country (2021-2026)
- 8.1.3 Europe Epilepsy Devices Sales Forecast by Country (2027-2032)
- 8.2 Europe Epilepsy Devices Market Size by Country
- 8.2.1 Europe Epilepsy Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Epilepsy Devices Market Size by Country (2021-2026)
- 8.2.3 Europe Epilepsy Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Epilepsy Devices Sales by Country
- 9.1.1 Asia-Pacific Epilepsy Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Epilepsy Devices Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Epilepsy Devices Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Epilepsy Devices Market Size by Country
- 9.2.1 Asia-Pacific Epilepsy Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Epilepsy Devices Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Epilepsy Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Epilepsy Devices Sales by Country
- 10.1.1 South America Epilepsy Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Epilepsy Devices Sales by Country (2021-2026)
- 10.1.3 South America Epilepsy Devices Sales Forecast by Country (2027-2032)
- 10.2 South America Epilepsy Devices Market Size by Country
- 10.2.1 South America Epilepsy Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Epilepsy Devices Market Size by Country (2021-2026)
- 10.2.3 South America Epilepsy Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Epilepsy Devices Sales by Country
- 11.1.1 Middle East and Africa Epilepsy Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Epilepsy Devices Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Epilepsy Devices Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Epilepsy Devices Market Size by Country
- 11.2.1 Middle East and Africa Epilepsy Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Epilepsy Devices Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Epilepsy Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Epilepsy Devices Value Chain Analysis
- 12.1.1 Epilepsy Devices Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Epilepsy Devices Production Mode & Process
- 12.2 Epilepsy Devices Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Epilepsy Devices Distributors
- 12.2.3 Epilepsy Devices Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst